Mrowietz, U; Sommer, R; Reguiai, Z; Gerdes, S; Dauden, E; Weger, W; Maul, JT; Laws, P; Naldi, L; Ghislain, PD; de Jong, E; Mburu, S; Koscielny, V; Massana, E; Kasujee, I; Kirsch, A; Augustin, M.
High Efficacy of Tildrakizumab regardless of Baseline Characteristics in Patients with moderate to severe Plaque Psoriasis: Interim Results from the POSITIVE Study at Week 52
J DTSCH DERMATOL GES. 2025; 23: 86-87.
Web of Science